Author

Yurou Xu

Observed name: Yurou XU

Institution: Fudan University

Observed institution: Fudan University

ORCID: 0009-0008-0201-1850

Observed ORCID: 0009-0008-0201-1850

OpenAlex ID: A5100585237

Prevalence, Incidence, and Recovery of Metabolic Dysfunction-associated Steatotic Liver Disease and Associations With Weight Loss and Lipid Reduction in a Chinese Community-based Cohort

2024 · Yurou Xu, Youyi Wang, et al. · Journal of Epidemiology · 10

Dairy products intake and prevalence, incidence, and recovery of non-alcoholic fatty liver disease in Chinese population

2024 · Yurou Xu, Youyi Wang, et al. · Hepatology International · 10

Sex, BMI, preoperative FIB-4 index, and iron supplementation were associated with postoperative anemia after laparoscopic sleeve gastrectomy among 619 Chinese patients: a retrospective cohort study

2025 · Bo Xu, Yurou Xu, et al. · Surgery for Obesity and Related Diseases · 2

Evaluation of the effectiveness of community-based management interventions based on the IMB model in ameliorating non-alcoholic fatty liver disease

2025 · Yifeng BU, Yi ZHENG, et al. · DOAJ (DOAJ: Directory of Open Access Journals)

Refined Carbohydrate, Different Staple Foods Intake and Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Community-Based Cohort Study

2025 · Yurou Xu, Xiajing Yao, et al. · The American Journal of Gastroenterology

Immune checkpoint inhibitors for advanced oesophageal cancer treated with surgery, radiotherapy or chemotherapy

2025 · Ning Cai, Yi Fung Chau, et al. · Cochrane Database of Systematic Reviews

Works count: 6

Citation count: 22

H-index: 2

I10-index: 2